Recruiting OBSERVATIONAL NCT05858307

Clinical Application of Serum Anti-Müllerian Hormone (AMH) Measurements

Sponsor: Chinese University of Hong Kong

Conditions Anti-Müllerian Hormone Fertility Issues Polycystic Ovarian Syndrome Premature Ovarian Insufficiency

Updated 4 times since 2023 Last updated: Mar 26, 2025 Started: Jun 22, 2022 Primary completion: Jun 30, 2026 Completion: Dec 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Anti-Müllerian Hormone and Fertility Issues and is currently actively recruiting participants. Chinese University of Hong Kong leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Apr 2025 — Present [monthly]

Recruiting
Sep 2024 — Apr 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Jun 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong